Interleukin-1 receptor antagonist gene polymorphism affects the progression of chronic renal failure

Cytokine

Volumn 36, Issue 3-4, 2006, Pages 167-172

  Buraczynska, Monika ^a   Ksiazek, Piotr ^a   Kubit, Piotr ^b   Zaluska, Wojciech ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b Ludwik Rydygier Speciality Hospital in Krakow   (Poland)

Author keywords

Disease progression; End stage renal disease; Gene polymorphism; IL 1 beta; IL 1 receptor antagonist

Indexed keywords

INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; RESTRICTION ENDONUCLEASE;

ADULT; ALLELE; ARTICLE; CHRONIC KIDNEY FAILURE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIGESTION; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; GENOTYPE; GLOMERULONEPHRITIS; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PERITONEAL DIALYSIS; PERITONITIS; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; RECURRENT DISEASE; RISK FACTOR; VARIABLE NUMBER OF TANDEM REPEAT;

ADULT; AGE FACTORS; CHOLESTEROL; DISEASE PROGRESSION; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1BETA; KIDNEY FAILURE, CHRONIC; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; POLYMORPHISM, GENETIC; RENAL DIALYSIS; SEX FACTORS; TANDEM REPEAT SEQUENCES;

EID: 33847018034     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2006.11.011     Document Type: Article

References (24)

1. Dinarello C.A. Biologic basis for interleukin-1 in disease. Blood 87 (1996) 2095-2147
2. Vamvakopoulos J., Green C., and Metcalfe S. Genetic control of IL-1 beta bioactivity through differential regulation of the IL-1 receptor antagonist. Eur J Immunol 32 (2002) 2988-2996
3. Arend W.P., and Gabay C. Physiologic role of interleukin-1 receptor antagonist. Arthritis Res 2 (2000) 245-248
4. Gabay C., Smith Jr. M., Eidlen D., and Arend W.P. Interleukin-1 receptor antagonist (IL-1Ra) is an acute phase protein. J Clin Invest 99 (1997) 2930-2940
5. Hurme M., and Santtila S. IL-1 receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL-1Ra and IL-1β genes. Eur J Immunol 28 (1998) 2598-2602
6. Tarlow J.K., Blakemore A.I.F., Lennard A., et al. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet 91 (1993) 403-404
7. Danis V.A., Millington M., Hayland V.J., and Grennan D. Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1RA) gene polymorphism. Clin Exp Immunol 99 (1995) 303-310
8. Schrijver H.M., Van AS J., Crusius J.B., et al. Interleukin IL-1 gene polymorphisms: Relevance of disease severity associated alleles with IL-1 beta and IL-1ra production in multiple sclerosis. Mediators Inflamm 12 (2003) 89-94
9. Blakemore A.I.F., Tarlow J.K., Cork M.J., et al. Interleukin-1 receptor antagonist polymorphism as a disease severity factor in systemic lupus erythematosus. Arthritis Rheum 37 (1994) 1380-1385
10. Sturfelt, Roux-Lombard P., Wollheim F.A., and Dayer J.M. Low levels of interleukin-1 receptor antagonist coincide with kidney involvement in systemic lupus erythematosus. Br J Rheumatol 36 (1997) 1283-1289
11. van der Paardt M., Crusius J.B., Garcia-Gonzalez M.A., et al. Interleukin-1β and interleukin-1 receptor antagonist gene polymorphisms in ankylosing spondylitis. Rheumatology 41 (2002) 1419-1423
12. Francis S.E., Camp N.J., Dewberry R.M., et al. Interleukin-1 receptor antagonist gene polymorphism and coronary artery disease. Circulation 99 (1999) 861-866
13. Erlinger T.P., Tarver-Carr M.E., Powe N.R., et al. Leukocytosis, hypoalbuminemia, and the risk for chronic kidney disease in U.S. adults. Am J Kidney Dis 42 (2003) 256-263
14. Guarnieri G., Grassi G., Barazzoni R., et al. The impact of inflammation on metabolic regulation in chronic kidney disease: a review. J Ren Nutr 15 (2005) 121-124
15. Blakemore A.I.F., Cox A., Gonzalez A.M., et al. Interleukin-1 receptor antagonist allele (IL1RN*2) associated with nephropathy in diabetes mellitus. Hum Genet 97 (1996) 369-374
16. Shu K.H., Lee S.H., Cheng C.H., et al. Impact of interleukin-1 receptor antagonist and tumor necrosis factor-α gene polymorphism on IgA nephropathy. Kidney Int 58 (2000) 783-789
17. Borgmann S., Endish G., Hacker U.T., et al. Proinflammatory genotype of interleukin-1 and interleukin-1 receptor antagonist is associated with ESRD in proteinase 3-ANCA vasculitis patients. Am J Kidney Dis 41 (2003) 933-942
18. Kim S.D., Park J.M., Kim I.S., et al. Association of IL-1 beta, IL-1ra, and TNF-alpha gene polymorphisms in childhood nephritic syndrome. Pediatr Nephrol 19 (2004) 295-299
19. Wetmore J.B., Hung A.M., Lovett D.H., et al. Interleukin-1 gene cluster polymorphisms predict risk of ESRD. Kidney Int 68 (2005) 278-284
20. Freedman B.I., Yu H., Spray B.J., et al. Genetic linkage analysis of growth factor loci and end-stage renal disease in African Americans. Kidney Int 51 (1997) 819-825
21. Loughrey B.V., Maxwell A.P., Fogarty D.G., et al. An interleukin 1B allele, which correlates with a high secretor phenotype, is associated with diabetic nephropathy. Cytokine 10 (1998) 984-988
22. Bioque G., Crusius J.B., Koutroubakis I., et al. Allelic polymorphism in IL-1 beta and IL-1 receptor antagonist (IL-1Ra) genes in inflammatory bowel disease. Clin Exp Immunol 102 (1995) 379-383
23. El-Omar E.M., Carrington M., Chow W.H., et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404 (2000) 398-402
24. Cullup H., Middleton P.G., Duggan G., et al. Environmental factors and not genotype influence the plasma level of interleukin-1 receptor antagonist in normal individuals. Clin Exp Immunol 137 (2004) 351-358